190 related articles for article (PubMed ID: 30610915)
1. A Phase 1/2 Trial of Reirradiation for Diffuse Intrinsic Pontine Glioma.
Amsbaugh MJ; Mahajan A; Thall PF; McAleer MF; Paulino AC; Grosshans D; Khatua S; Ketonen L; Fontanilla H; McGovern SL
Int J Radiat Oncol Biol Phys; 2019 May; 104(1):144-148. PubMed ID: 30610915
[TBL] [Abstract][Full Text] [Related]
2. Radiation and subsequent reirradiation outcomes in the treatment of diffuse intrinsic pontine glioma and a systematic review of the reirradiation literature.
Freese C; Takiar V; Fouladi M; DeWire M; Breneman J; Pater L
Pract Radiat Oncol; 2017; 7(2):86-92. PubMed ID: 28274399
[TBL] [Abstract][Full Text] [Related]
3. Reirradiation and PD-1 inhibition with nivolumab for the treatment of recurrent diffuse intrinsic pontine glioma: a single-institution experience.
Kline C; Liu SJ; Duriseti S; Banerjee A; Nicolaides T; Raber S; Gupta N; Haas-Kogan D; Braunstein S; Mueller S
J Neurooncol; 2018 Dec; 140(3):629-638. PubMed ID: 30206764
[TBL] [Abstract][Full Text] [Related]
4. Survival benefit for patients with diffuse intrinsic pontine glioma (DIPG) undergoing re-irradiation at first progression: A matched-cohort analysis on behalf of the SIOP-E-HGG/DIPG working group.
Janssens GO; Gandola L; Bolle S; Mandeville H; Ramos-Albiac M; van Beek K; Benghiat H; Hoeben B; Morales La Madrid A; Kortmann RD; Hargrave D; Menten J; Pecori E; Biassoni V; von Bueren AO; van Vuurden DG; Massimino M; Sturm D; Peters M; Kramm CM
Eur J Cancer; 2017 Mar; 73():38-47. PubMed ID: 28161497
[TBL] [Abstract][Full Text] [Related]
5. Clinical approach to re-irradiation for recurrent diffuse intrinsic pontine glioma.
Krishnatry R; Manjali JJ; Chinnaswamy G; Chatterjee A; Goda JS; Janu A; Sahu A; Jalali R; Gupta T
Jpn J Clin Oncol; 2021 Apr; 51(5):762-768. PubMed ID: 33521824
[TBL] [Abstract][Full Text] [Related]
6. Reirradiation for diffuse intrinsic pontine glioma: a systematic review and meta-analysis.
Lu VM; Welby JP; Mahajan A; Laack NN; Daniels DJ
Childs Nerv Syst; 2019 May; 35(5):739-746. PubMed ID: 30879125
[TBL] [Abstract][Full Text] [Related]
7. Reirradiation in patients with diffuse intrinsic pontine gliomas: The Canadian experience.
Lassaletta A; Strother D; Laperriere N; Hukin J; Vanan MI; Goddard K; Lafay-Cousin L; Johnston DL; Zelcer S; Zapotocky M; Rajagopal R; Ramaswamy V; Hawkins C; Tabori U; Huang A; Bartels U; Bouffet E
Pediatr Blood Cancer; 2018 Jun; 65(6):e26988. PubMed ID: 29369515
[TBL] [Abstract][Full Text] [Related]
8. A phase I trial of etanidazole and hyperfractionated radiotherapy in children with diffuse brainstem glioma.
Marcus KJ; Dutton SC; Barnes P; Coleman CN; Pomeroy SL; Goumnerova L; Billett AL; Kieran M; Tarbell NJ
Int J Radiat Oncol Biol Phys; 2003 Apr; 55(5):1182-5. PubMed ID: 12654425
[TBL] [Abstract][Full Text] [Related]
9. High-dose salvage re-irradiation for recurrent/progressive adult diffuse glioma: healing or hurting?
Gupta T; Maitre M; Maitre P; Goda JS; Krishnatry R; Chatterjee A; Moiyadi A; Shetty P; Epari S; Sahay A; Patil V; Jalali R
Clin Transl Oncol; 2021 Jul; 23(7):1358-1367. PubMed ID: 33528810
[TBL] [Abstract][Full Text] [Related]
10. Reirradiation for Recurrent Pediatric Central Nervous System Malignancies: A Multi-institutional Review.
Rao AD; Rashid AS; Chen Q; Villar RC; Kobyzeva D; Nilsson K; Dieckmann K; Nechesnyuk A; Ermoian R; Alcorn S; MacDonald SM; Ladra MM; Ford EC; Winey BA; Figueiredo MLS; Chen MJ; Terezakis SA
Int J Radiat Oncol Biol Phys; 2017 Nov; 99(3):634-641. PubMed ID: 29280457
[TBL] [Abstract][Full Text] [Related]
11. Hypofractionation vs conventional radiation therapy for newly diagnosed diffuse intrinsic pontine glioma: a matched-cohort analysis.
Janssens GO; Jansen MH; Lauwers SJ; Nowak PJ; Oldenburger FR; Bouffet E; Saran F; Kamphuis-van Ulzen K; van Lindert EJ; Schieving JH; Boterberg T; Kaspers GJ; Span PN; Kaanders JH; Gidding CE; Hargrave D
Int J Radiat Oncol Biol Phys; 2013 Feb; 85(2):315-20. PubMed ID: 22682807
[TBL] [Abstract][Full Text] [Related]
12. The role of hypofractionation radiotherapy for diffuse intrinsic brainstem glioma in children: a pilot study.
Janssens GO; Gidding CE; Van Lindert EJ; Oldenburger FR; Erasmus CE; Schouten-Meeteren AY; Kaanders JH
Int J Radiat Oncol Biol Phys; 2009 Mar; 73(3):722-6. PubMed ID: 18990510
[TBL] [Abstract][Full Text] [Related]
13. Bevacizumab reduces toxicity of reirradiation in recurrent high-grade glioma.
Fleischmann DF; Jenn J; Corradini S; Ruf V; Herms J; Forbrig R; Unterrainer M; Thon N; Kreth FW; Belka C; Niyazi M
Radiother Oncol; 2019 Sep; 138():99-105. PubMed ID: 31252301
[TBL] [Abstract][Full Text] [Related]
14. Palliative reirradiation for progressive diffuse intrinsic pontine glioma.
Fontanilla HP; Pinnix CC; Ketonen LM; Woo SY; Vats TS; Rytting ME; Wolff JE; Mahajan A
Am J Clin Oncol; 2012 Feb; 35(1):51-7. PubMed ID: 21297433
[TBL] [Abstract][Full Text] [Related]
15. Repeat irradiation for children with supratentorial high-grade glioma.
Tsang DS; Oliveira C; Bouffet E; Hawkins C; Ramaswamy V; Yee R; Tabori U; Bartels U; Huang A; Millar BA; Crooks B; Bowes L; Zelcer S; Laperriere N
Pediatr Blood Cancer; 2019 Sep; 66(9):e27881. PubMed ID: 31207154
[TBL] [Abstract][Full Text] [Related]
16. Radiation dose response of neurologic symptoms during conformal radiotherapy for diffuse intrinsic pontine glioma.
Tinkle CL; Campbell K; Han Y; Li Y; Bianski B; Broniscer A; Khan RB; Merchant TE
J Neurooncol; 2020 Mar; 147(1):195-203. PubMed ID: 32016716
[TBL] [Abstract][Full Text] [Related]
17. The addition of high-dose tamoxifen to standard radiotherapy does not improve the survival of patients with diffuse intrinsic pontine glioma.
Michalski A; Bouffet E; Taylor RE; Hargrave D; Walker D; Picton S; Robinson K; Pizer B; Bujkiewicz S
J Neurooncol; 2010 Oct; 100(1):81-8. PubMed ID: 20238235
[TBL] [Abstract][Full Text] [Related]
18. Fractionated stereotactic conformal radiation therapy of brain stem gliomas: outcome and prognostic factors.
Schulz-Ertner D; Debus J; Lohr F; Frank C; Höss A; Wannenmacher M
Radiother Oncol; 2000 Nov; 57(2):215-23. PubMed ID: 11054526
[TBL] [Abstract][Full Text] [Related]
19. Phase I study of vandetanib during and after radiotherapy in children with diffuse intrinsic pontine glioma.
Broniscer A; Baker JN; Tagen M; Onar-Thomas A; Gilbertson RJ; Davidoff AM; Pai Panandiker AS; Leung W; Chin TK; Stewart CF; Kocak M; Rowland C; Merchant TE; Kaste SC; Gajjar A
J Clin Oncol; 2010 Nov; 28(31):4762-8. PubMed ID: 20921456
[TBL] [Abstract][Full Text] [Related]
20. Prospective evaluation of radiotherapy with concurrent and adjuvant temozolomide in children with newly diagnosed diffuse intrinsic pontine glioma.
Jalali R; Raut N; Arora B; Gupta T; Dutta D; Munshi A; Sarin R; Kurkure P
Int J Radiat Oncol Biol Phys; 2010 May; 77(1):113-8. PubMed ID: 19647954
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
